GRB2 and tuberculosis: Using the approach described in Methods 2.10, we identified 10 key in-path genes linking TB disease genes and drug targets, including MYD88, RELA, CXCR2, UBC, GRB2, CBL, TIMP1, TRAF6, IL8, TP53 (Figure 3; Table 3).